| abstract |
Substituted imidazoles such as 2-butyl-4-chloro-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-5-(hydroxymethyl)imidazole nand 2-butyl-4-chloro-1-[(2'-carboxybiphenyl-4-yl)-methyl]-5-(hydroxymethyl)imidazole nand pharmaceutically acceptable salts thereof are useful for ntreating central nervous system disorders, such as cognitive nand learning disorders, mediated by angiotensin II. |